Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities NTLA - Intellia Therapeutics, Inc.
-31.3 M
LAST VALUE
76.14%
2 YEAR CAGR
34.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR